Oliver Tracie has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 9394 shares of ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) on July 02, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Oliver Tracie | Chief Commercial Officer | S | Common Stock | 9394 | $25.28 | 127,107.0000 | 124,199,000 | 6.88% | 0.01% |
| Jan. 4, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Oliver Tracie | Chief Commercial Officer | A | Common Stock | 75000 | $0.00 | 136,575.0000 | 106,750,000 | 121.80% | 0.07% |
| Jan. 5, 2024 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Oliver Tracie | Chief Commercial Officer | S | Common Stock | 74 | $33.89 | 136,501.0000 | 106,750,000 | 0.05% | 0.00% |